Table 4

Expression level of CDX2 in patients with AML and normal karyotype

AML-NK subgroup analysisAverage ΔCT (± SD)
NPM+/FLT3+ 8.26 (± 2.84) 
NPM+/FLT3− 7.74 (± 2.27) 
NPM−/FLT3+ 7.27 (± 2.91) 
NPM−/FLT3− 7.18 (± 2.48) 
AML-NK subgroup analysisAverage ΔCT (± SD)
NPM+/FLT3+ 8.26 (± 2.84) 
NPM+/FLT3− 7.74 (± 2.27) 
NPM−/FLT3+ 7.27 (± 2.91) 
NPM−/FLT3− 7.18 (± 2.48) 

NK indicates normal karyotype; and FLT3, FLT3 mutation.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal